New therapeutic target for C. difficile infection

A new study paves the way for the development of next generation therapeutics for the prevention and treatment of Clostridioides difficile infection (CDI), the most frequent cause of healthcare-acquired gastrointestinal infections and death in developed countries.
https://www.sciencedaily.com/releases/2021/06/210618134107.htm?utm_source=dlvr.it&utm_medium=blogger